Keene & Associates’s Oracle ORCL Stock Holding History

Keene & Associates’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$4.13M	Sell	24,801 -2,009	-7%	-$357K	3.32%	7
2024 Q3	$4.57M	Sell	26,810 -861	-3%	-$125K	3.46%	2
2024 Q2	$3.91M	Sell	27,671 -564	-2%	-$70K	3.19%	5
2024 Q1	$3.55M	Sell	28,235 -46	-0.2%	-$5.26K	2.65%	12
2023 Q4	$2.98M	Sell	28,281 -286	-1%	-$31.2K	2.47%	22
2023 Q3	$3.03M	Sell	28,567 -3,223	-10%	-$373K	2.43%	18
2023 Q2	$3.79M	Sell	31,790 -6,851	-18%	-$708K	2.94%	10
2023 Q1	$3.59M	Sell	38,641 -2,513	-6%	-$220K	2.78%	11
2022 Q4	$3.36M	Buy	41,154 +863	+2%	+$65.6K	3%	10
2022 Q3	$2.46M	Buy	40,291 +1,259	+3%	+$92.2K	2.26%	25
2022 Q2	$2.73M	Buy	39,032 +561	+1%	+$41.1K	2.55%	24
2022 Q1	$3.18M	Buy	38,471 +5,850	+18%	+$474K	2.6%	21
2021 Q4	$2.85M	Buy	+32,621	New	+$3.06M	2.46%	24

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Keene & Associates's ORCL Position: Q4 2024 in Review

Keene & Associates reduced its Oracle (ORCL) stake by 7.5% in Q4 2024, selling an estimated $357K and leaving 24,801 shares worth $4.13M. The position accounts for 3.32% of the portfolio, ranked #7.

Keene & Associates first reported a position in ORCL in Q4 2021 and has held it in 13 quarters since. The position peaked at $4.57M in Q3 2024. 3,342 funds tracked by Wall St. Rank hold ORCL as of Q4 2024.

Keene & Associates held 24,801 shares of Oracle worth $4.13M as of Q4 2024.
Keene & Associates sold 2,009 Oracle shares in Q4 2024, an estimated $357K.
Oracle made up 3.32% of Keene & Associates's portfolio in Q4 2024, its #7 holding.
Keene & Associates first reported a position in Oracle in Q4 2021 and has held it in 13 quarters since.
Keene & Associates's Oracle position peaked at $4.57M in Q3 2024.
3,342 funds tracked by Wall St. Rank held Oracle as of Q4 2024.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.